BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands
Magellan Diagnostics admits that it misled customers and the FDA about a device malfunction that produced inaccurately low results in lead level blood tests for potentially tens of thousands of children and other patients.
Update Magellan Diagnostics to pay $42M to settle lead case bostonglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonglobe.com Daily Mail and Mail on Sunday newspapers.
A Massachusetts-based company will plead guilty to resolve allegations that it knowingly concealed a flaw in its lead blood tests that caused numerous inaccurate results.